In certain tumors, limited evidence suggested that SLIT3 might be involved in the activation of cancer-promoting signaling pathways such as the ERK/MAPK and GSK3β/β-catenin signaling pathways [14,15]. The gene discussed is SLIT3; the disease is cancer.